1926
K. S. Griswold et al.
CLUSTER
(11) Compounds 3 and 4 were prepared by the reaction of L-
proline methylester with either 4-chlorophenylsulfonyl
isocyanate or p-toluenesulfonyl isocyanate according to the
following procedure: To a solution of L-proline methylester
hydrogen chloride (48.0 mg, 0.289 mmol) in CH2Cl2 (720
mL) stirring at 0 °C was added Et3N (40.0 mL, 0.289 mmol).
Isocyanate was then added dropwise and the reaction was
allowed to warm to 25 °C. The reaction was allowed to stir
for 30 min at 25 °C and was then diluted with 5 mL of
CH2Cl2 and washed with 1 N HCl. The organic layer was
dried over Na2SO4 and concentrated in vacuo. The resulting
residue was chromatographed on silica gel with 0–5%
MeOH/CH2Cl2 (>95% yield). Data for 3: 1H NMR (400
MHz, CDCl3): d = 7.96 (d, J = 8.4 Hz, 2 H), 7.32 (d, J = 8.1
Hz, 2 H), 4.40 (dd, J = 8.4, 3.9 Hz, 1 H), 3.70 (s, 3 H), 3.56–
3.34 (m, 2 H), 2.43 (s, 3 H), 2.20–1.81 (m, 4 H). 13C NMR
(100 MHz, CDCl3): d = 172.2, 150.5, 144.4, 136.3, 129.4,
128.3, 59.1, 52.5, 46.5, 29.5, 24.5, 21.6. IR (film): 3245,
2948, 1747, 1676, 1456, 1379, 1325, 1171 cm–1. TLC: Rf =
0.50 (10% MeOH/CH2Cl2). Exact mass calcd for
by TLC, the suspension was filtered through a layer of celite
and concentrated in vacuo. The resulting residue was
subjected to flash chromatography on silica gel, eluting with
5% EtOAc/hexanes. The products are isolated as a mixture
of a/b anomers, which could be assigned by 1H NMR
spectroscopy.
(14) Compound 2 has been characterized previously: Hosono, S.;
Kim, W.-S.; Sasai, H.; Shibisaki, M. J. Org. Chem. 1995, 60,
4.
(15) (a) Characterization data for compound 6: a-anomer: 1H
NMR (400 MHz, CDCl3): d = 7.36–7.12 (m, 20 H), 4.99 (d,
J = 11.0 Hz, 1 H), 4.84–4.75 (m, 4 H), 4.66–4.59 (m, 2 H),
4.47 (d, J = 12.1 Hz, 2 H), 3.99 (t, J = 9.3 Hz, 1 H), 3.79–
3.72 (m, 2 H), 3.65–3.54 (m, 4 H), 3.44–3.39 (m, 1 H), 1.64–
1.58 (m, 2 H), 1.23 (bs, 10 H), 0.88 (t, J = 6.8 Hz, 3 H). 13
NMR (100 MHz, CDCl3): d = 138.8, 138.2, 138.1, 137.8,
128.2, 127.9, 127.8, 127.7, 127.5, 127.4, 96.8, 82.1, 80.1,
C
77.8, 75.7, 75,1, 73.5, 73.1, 70.1, 68.6, 68.3, 32.0, 29.5, 29.4,
26.3, 22.8, 14.3. IR(film): 3089, 3063, 3030, 2926, 2856 cm–
1. TLC: Rf = 0.39 (20% EtOAc/hexanes). Anal. Calcd for
C42H52O6: C, 77.27; H, 8.03. Found: C, 76.94; H, 8.05. b-
Anomer 1H NMR (400 MHz, CDCl3): d = 7.36–7.14 (m, 20
H), 4.95 (t, J = 11.0 Hz, 2 H), 4 .80 (t, J = 11.4 Hz, 2 H), 4.72
(d, J = 11.0 Hz, 1 H), 4.63–4.51 (m, 3 H), 4.39 (d, J = 7.7
Hz, 1 H), 3.99–3.94 (m, 1 H), 3.75 (dd, J = 10.8, 2.0 Hz, 1
H), 3.69–3.43 (m, 6 H), 1.68–1.62 (m, 2 H), 1.42–1.26 (m,
10 H), 0.87 (t, J = 7.0 Hz, 3 H). 13C NMR (100 MHz, CDCl3)
d = 138.5, 138.3, 138.0, 137.9, 128.2, 128.0, 127.8, 127.7,
127.6, 127.5, 127.4, 123.6, 84.7, 82.8, 77.9, 75.7, 75.0, 74.8,
73.4, 70.1, 69.0, 31.9, 29.9, 29.5, 29.4, 26.3, 22.8, 14.2. IR
(film): 3087, 3063, 3032, 2927, 2857 cm–1. TLC: Rf = 0.50
(20% EtOAc/hexanes). Anal. Calcd for C42H52O6: C, 77.27;
H, 8.03. Found: C, 77.00; H, 8.00.
[C14H18N2O5NaS] requires m/z 349.0834. Found: 349.0827
(ESI+). Data for compound 4: 1H NMR (400 MHz, CDCl3):
d = 8.03 (d, J = 8.9 Hz, 2 H), 7.50 (d, J = 8.8 Hz, 2 H), 4.41
(dd, J = 8.7, 3.8 Hz, 1 H), 3.82–3.63 (m, 1 H), 3.72 (s, 3 H),
3.54–3.34 (m, 1 H), 2.20–1.86 (m, 4 H). 13C NMR (100
MHz, CDCl3): d = 172.0, 150.4, 139.7, 137.4, 129.5, 128.8,
59.1, 52.3, 46.5, 29.4, 24.1. IR(film): 3245, 2954, 1747,
1670, 1456, 1379, 1183 cm–1. TLC: Rf = 0.40 (10% MeOH/
CH2Cl2). Exact mass calcd for [C13H15 N2O5Na1S1Cl1]
requires m/z 369.0288. Found: 369.0282 (ESI+).
(12) All compounds gave satisfactory analytical data.
(13) The general experimental procedure is as follows:
Trichloroacetimidate 1 (50.0 mg, 0.0730 mmol) was
suspended in methylene chloride (300 mL). The glycosyl
acceptor (0.0487 mmol) was then introduced, followed by
the addition of activated 4 Å molecular sieves (50.0 mg).
The solution was allowed to stir at 25 °C for 10 min upon
which a stock solution of catalyst was added (50.0 mL,
0.00730 mmol). When the reaction was judged to be finished
(16) For compounds 7 and 8, see: Garcia, B. A.; Gin, D. Y. J. Am.
Chem. Soc. 2000, 122, 4269.
(17) For compound 9, see: (a) Nishizawa, M.; Garcia, D. M.;
Shin, T.; Yamada, H. Chem. Pharm. Bull. 1993, 41, 784.
(b) Mukaiyama, T.; Takashima, T.; Katsurada, M.; Aizawa,
H. Chem. Lett. 1991, 533.
Synlett 2003, No. 12, 1923–1926 © Thieme Stuttgart · New York